EndocanENDO

13F holders, Q1 2024 (March 31)
1holders
$0.00avg. 13F price*

At the end of Q1 2024, 1 institutions reported holding Endocan Corp. (ENDO) in their 13F filings. The largest holder was HighPoint Advisor Group LLC ($0).

Company
Endocan Corp.
CUSIP
29271J109
Latest filing quarter
Q4 2024

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024

Total Exit/New Position Q1 2024

No earlier quarter to compare with.

Ownership 1 holders

HighPoint Advisor Group LLC 0.00% No change 12,000 $0

"% of holder's portfolio" is ENDO's weight in each manager's 13F, not the share of Endocan Corp. the manager owns.